Global Medical REIT Inc (NASDAQ:GMRE) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Tuesday.

According to Zacks, “Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. “

Several other research firms have also recently commented on GMRE. DA Davidson began coverage on Global Medical REIT in a research report on Tuesday, July 26th. They set a “buy” rating and a $12.00 target price for the company. Oppenheimer Holdings Inc. began coverage on Global Medical REIT in a research report on Monday, July 25th. They set an “outperform” rating and a $12.00 target price for the company. Compass Point cut Global Medical REIT from a “buy” rating to a “neutral” rating in a research report on Tuesday, September 20th. Finally, Wunderlich cut Global Medical REIT from a “buy” rating to a “hold” rating in a research report on Thursday, November 10th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $11.65.

Analyst Recommendations for Global Medical REIT (NASDAQ:GMRE)

Global Medical REIT (NASDAQ:GMRE) opened at 7.36 on Tuesday. Global Medical REIT has a 52-week low of $6.73 and a 52-week high of $11.38. The firm has a 50-day moving average price of $8.66 and a 200 day moving average price of $9.82.

Global Medical REIT (NASDAQ:GMRE) last released its quarterly earnings data on Thursday, November 10th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by $0.02. The company earned $2 million during the quarter, compared to the consensus estimate of $2.40 million. On average, analysts expect that Global Medical REIT will post ($0.54) EPS for the current fiscal year.

Institutional investors have recently bought and sold shares of the company. Crow Point Partners LLC purchased a new position in Global Medical REIT during the third quarter worth about $8,882,000. BlackRock Fund Advisors purchased a new position in Global Medical REIT during the third quarter worth about $4,242,000. Emerald Mutual Fund Advisers Trust boosted its position in Global Medical REIT by 3.0% in the third quarter. Emerald Mutual Fund Advisers Trust now owns 394,420 shares of the company’s stock worth $3,850,000 after buying an additional 11,310 shares during the last quarter. Emerald Advisers Inc. PA purchased a new position in Global Medical REIT during the second quarter worth about $3,709,000. Finally, Manning & Napier Advisors LLC boosted its position in Global Medical REIT by 77.4% in the third quarter. Manning & Napier Advisors LLC now owns 354,890 shares of the company’s stock worth $3,462,000 after buying an additional 154,890 shares during the last quarter.

WARNING: This piece was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another publication, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be read at https://www.thecerbatgem.com/2016/11/24/global-medical-reit-inc-gmre-rating-increased-to-hold-at-zacks-investment-research.html.

Global Medical REIT Company Profile

Global Medical REIT Inc focuses on operating as a real estate investment trust. The Company is engaged primarily in the acquisition and leasing of licensed purpose-built healthcare facilities in certain markets with various clinical operators. The Company seeks to invest in these purpose-built, specialized facilities, such as surgery centers, specialty hospitals and outpatient treatment centers.

5 Day Chart for NASDAQ:GMRE

Receive News & Stock Ratings for Global Medical REIT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc and related stocks with our FREE daily email newsletter.